Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

BOEHRINGER INGELHEIM

  • FDA Approval
  • May 01, 2024, 12:59 UTC
  • 64
  • 0 comments

FDA approve ADALIMUMAB-ADBM

Comment Full text

AURINIA

  • FDA Approval
  • April 30, 2024, 18:05 UTC
  • 67
  • 0 comments

FDA approve VOCLOSPORIN

Comment Full text

TEVA

  • FDA Approval
  • April 30, 2024, 09:09 UTC
  • 47
  • 0 comments

FDA approve AMOXICILLIN; CLAVULANATE POTASSIUM

Comment Full text

SANDOZ

  • FDA Approval
  • April 30, 2024, 09:09 UTC
  • 56
  • 0 comments

FDA approve AMOXICILLIN

Comment Full text

PHARMAESSENTIA CORP

  • FDA Approval
  • April 30, 2024, 09:09 UTC
  • 52
  • 0 comments

FDA approve ROPEGINTERFERON ALFA-2B-NJFT

Comment Full text

CONCORDIA

  • FDA Approval
  • April 30, 2024, 09:09 UTC
  • 53
  • 0 comments

FDA approve DIGOXIN

Comment Full text

ALEMBIC

  • FDA Approval
  • April 30, 2024, 09:09 UTC
  • 46
  • 0 comments

FDA approve DIAZEPAM

Comment Full text

SANDOZ

  • FDA Approval
  • April 30, 2024, 09:09 UTC
  • 44
  • 0 comments

FDA approve AMOXICILLIN

Comment Full text

CHARTWELL RX

  • FDA Approval
  • April 30, 2024, 09:09 UTC
  • 58
  • 0 comments

FDA approve AMOXICILLIN

Comment Full text

BAUSCH AND LOMB

  • FDA Approval
  • April 30, 2024, 09:09 UTC
  • 46
  • 0 comments

FDA approve BRINZOLAMIDE

Comment Full text
  • Previous
  • 464
  • 465
  • 466
  • 467
  • 468
  • Next

Search

News categories

  • Technical Exchange News(14691)
  • Event(6229)
  • SEC News(393605)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(239488)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin